Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib Meeting Abstract


Authors: Byrd, J. C.; Wierda, W. G.; Davids, M. S.; Choi, M. Y.; Furman, R. R.; Mato, A. R.; Zhou, L.; Verdugo, M. E.; Potluri, J.; Coutre, S.
Abstract Title: Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 402s
Language: English
ACCESSION: WOS:000442916002582
DOI: 10.1200/JCO.2018.36.15_suppl.7512
PROVIDER: wos
Notes: Meeting Abstract: 7512 -- Source: Wos
Altmetric Score
MSK Authors
  1. Anthony R Mato
    16 Mato